Polarean Imaging (POLX LN)

Analysis

Health Care • United Kingdom

Polarean Imaging is a medical imaging technology company focused on advancing its XENOVIEW MRI Platform, an FDA-approved functional lung imaging platform. The company develops and commercializes gas polarizer devices, ancillary instruments, and the hyperpolarized xenon MRI inhaled contrast agent, XENOVIEW, to enable direct, quantitative, regional assessment of lung ventilation using MRI. Polarean Imaging is headquartered in Durham, North Carolina, and was founded in 2012.

Refresh

Exchange Announcement • 16 Dec 2025 00:03

Result of General Meeting

Exchange Announcement • 01 Dec 2025 15:00

Chest coil passes Philips compatibility testing

Exchange Announcement • 25 Nov 2025 15:00

First Xenon Hyperpolariser in Asia

Exchange Announcement • 24 Nov 2025 15:00

Korean distributor agreement with DK Healthcare

Exchange Announcement • 14 Nov 2025 15:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Result of General Meeting

Chest coil passes Philips compatibility testing

First Xenon Hyperpolariser in Asia

Korean distributor agreement with DK Healthcare

Proposed Cancellation of Admission & Notice of GM